Mission
The mission of the HESI Cardiac Safety Technical Committee is to develop and disseminate improved data, approaches, and resources for the evaluation of preclinical and clinical cardiac toxicity.
|
 Committee Factsheet
Committee Publications
Committee Events
Committee Presentations and Data Resources
|
|
Committee Participation
2010 Government and Academic Participants
Duke University
Karolinska Institute
National Institutes of Health
Spanish Agency on Medicines and Healthcare Products
University of Miami
University of Minnesota
University of Wisconsin
US Food and Drug Administration
2010 Committee Membership
Abbott Laboratories
Amgen Inc.
AstraZeneca AB
Bayer HealthCare Pharmaceuticals
Bristol-Myers Squibb Company
Covance
Eli Lilly and Company
F. Hoffman-La Roche
GlaxoSmithKline
Johnson & Johnson Pharmaceuticals
Merck & Co., Inc.
Novartis Pharmaceuticals
Pfizer, Inc.
sanofi-aventis
Schering Plough Research Institute
|
|
Contact:
HESI Staff:
Syril Pettit, MS, spettit@hesiglobal.org
(202) 659-3306
|
